Medidata Expands Collaboration with CTI Clinical Trial and Consulting, Shaping a New Era of Patient-Centric Studies Medidata Patient Experience will accelerate CTI’s treatments for patients with oncology, metabolic, cardiovascular, central nervous system, and immune conditions NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- , a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, and (CTI), a global leader in research services for advanced therapies, have expanded their 12-year relationship. The new agreement places the and its essential,...
Temenos Earns 2025 Great Place To Work Certification™ Across 15 Locations Temenos now certified in the US, India, Ecuador, Hong Kong and Taiwan in addition to 10 locations announced earlier this year GRAND-LANCY, Switzerland, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Temenos (SIX: TEMN), a global leader in banking technology, today announced it has been Certified™ by To Work® in 15 locations in 2025. Following certification in , Temenos has recently been recognized as a Great Place to Work in an additional five locations: United States, India, Ecuador, Hong Kong and Taiwan. Great Place To Wor...
A director at Temenos AG sold/sold after exercising options 7,849 shares at 75.850CHF and the significance rating of the trade was 78/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over th...
Medidata Unveils Next-Generation Patient Consent Innovations, Designed in Partnership with Clinicians and Patient Advocates Medidata Consent, a key part of the , expedites study start-up, reduces configuration complexity, and improves patient enrollment NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- , a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced notable advances to , its industry-proven electronic informed consent technology. Delivered through the , this modern solution reimagines patient consent in clinical trial...
UPDATE - Medidata Extends Collaboration with Sanofi for the Development of New Therapies with an Improved Patient Journey Expanded 10-plus-year collaboration will leverage Medidata Experiences with the goal of streamlining clinical processes and data, enhancing patient care NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- , a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced an extension of their collaboration with Sanofi in clinical research. As part of this extension Sanofi will use the , building on the organizations’ v...
Orange has reported a solid set of results, with Telco revenue and EBITDA in-line with consensus expectations; Bank losses are lower than expected and Group EBITDAaL guidance has been lifted as a result (despite a small downgrade to OBS guidance).
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.